✦ LIBER ✦

PDB44 THE COST-EFFECTIVENESS OF SAXAGLIPTIN VERSUS SULFONYLUREA (SU) IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS (T2DM) IN GERMANY

✍ Scribed by W Erhardt; K Bergenheim; R Townsend; J Puelles Fernandez de Troconiz; P McEwan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PDB37 THE COST-EFFECTIVENESS OF SAXAGLIP

✍ K Kolasa; M Niewada; J Puelles Fernandez de Troconiz; R Townsend; P McEwan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

Cost Effectiveness of Saxagliptin and Me

✍ Wilma Erhardt, Klas Bergenheim, Isabelle Duprat-Lomon, Dr Phil McEwan 📂 Article 📅 2012 🏛 Springer International Publishing AG 🌐 English ⚖ 372 KB

PDB45 COST-EFFECTIVENESS ANALYSIS OF SAX

✍ de Ramirez; A Arellano; M Brosa; J Franch; D Mauricio; C Alvarez; M Sanchez-Zamo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

PDB9 Cost-Effectiveness Analysis of Saxa

✍ E.E. Arinina; M. Rashyd 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PDB39 Cost-Effectiveness of Saxagliptin

✍ Hutchings, A.; Tolley, K.; Achana, F.; Brereton, N.J.; Lebmeier, M.; Mesa, O.A. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

PDB27 COST-EFFECTIVENESS ANALYSIS OF MET

✍ J. Elgart; J. Caporale; E.C. Aiello; M. Waschbusch; L. Jotimliansky; J.J. Gaglia 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB